PD-1 inhibition in metastatic dMMR/MSI-H colorectal cancer

被引：42
|
作者：
Sclafani, Francesco [1 ]
机构：
[1] Royal Marsden NHS Fdn Trust, Sutton SM2 5PT, Surrey, England
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 09期
关键词：
D O I：
10.1016/S1470-2045(17)30512-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1141 / 1142
页数：3
相关论文
共 50 条
  • [1] Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer
    Oliveira, Andre F.
    Bretes, Luis
    Furtado, Irene
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [2] Immunotherapy Promising for Metastatic MSI-H/dMMR Colorectal Cancer
    Yarden, Ronit
    [J]. ONCOLOGY-NEW YORK, 2019, 33 (05): : 179 - 179
  • [3] Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
    Margalit, Ofer
    Stemmer, Amos
    Chapin, William J.
    Shacham-Shmueli, Einat
    Kopetz, Scott
    Andre, Thierry
    Overman, Michael J.
    Pietrantonio, Filippo
    Boursi, Ben
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [4] PD-1 blockade combined with COX inhibitor in patients with MSI-H/dMMR or high TMB, advanced or metastatic colorectal cancer (PCOX study)
    Wu, Zehua
    Hu, Huabin
    Zhang, Jianwei
    Cai, Yue
    Xie, Xiaoyu
    Ling, Jiayu
    Li, Weiwei
    Deng, Yanhong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [5] Efficacy of PD-1 blockade in patients with dMMR/MSI-H metastatic colorectal versus gastric cancers: A large, multicenter, cohort study
    Mazzoli, G.
    Nichetti, F.
    Shitara, K.
    Cohen, R.
    Lonardi, S.
    Elez, E.
    Fakih, M.
    Klempner, S.
    Jayachandran, P.
    Maron, S.
    Fornaro, L.
    Salvatore, L.
    Valerie, Z.
    Aoki, Y.
    Ambrosini, M.
    Cremolini, C.
    Randon, G.
    Overman, M.
    Andre, T.
    Pietrantonio, F.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S11 - S12
  • [6] Opportunities and challenges of immunotherapy for dMMR/MSI-H colorectal cancer
    Qi Zhang
    Jian Li
    Lin Shen
    Yongsheng Li
    Xicheng Wang
    [J]. Cancer Biology & Medicine., 2023, 20 (10) - 712
  • [7] Opportunities and challenges of immunotherapy for dMMR/ MSI-H colorectal cancer
    Zhang, Qi
    Li, Jian
    Shen, Lin
    Li, Yongsheng
    Wang, Xicheng
    [J]. CANCER BIOLOGY & MEDICINE, 2023, 20 (10) : 706 - 712
  • [8] Opportunities and challenges of immunotherapy for dMMR/MSI-H colorectal cancer
    Qi Zhang
    Jian Li
    Lin Shen
    Yongsheng Li
    Xicheng Wang
    [J]. Cancer Biology & Medicine, 2023, (10) : 706 - 712
  • [9] Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
    Fuca, Giovanni
    Cohen, Romain
    Lonardi, Sara
    Shitara, Kohei
    Elena Elez, Maria
    Fakih, Marwan
    Chao, Joseph
    Klempner, Samuel J.
    Emmett, Matthew
    Jayachandran, Priya
    Bergamo, Francesca
    Diez Garcia, Marc
    Mazzoli, Giacomo
    Provenzano, Leonardo
    Colle, Raphael
    Svrcek, Magali
    Ambrosini, Margherita
    Randon, Giovanni
    Shah, Aakash Tushar
    Salati, Massimiliano
    Fenocchio, Elisabetta
    Salvatore, Lisa
    Chida, Keigo
    Kawazoe, Akihito
    Conca, Veronica
    Curigliano, Giuseppe
    Corti, Francesca
    Cremolini, Chiara
    Overman, Michael
    Andre, Thierry
    Pietrantonio, Filippo
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)
  • [10] Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
    Mulet-Margalef, Nuria
    Linares, Jenniffer
    Badia-Ramentol, Jordi
    Jimeno, Mireya
    Monte, Carolina Sanz
    Mozo, Jose Luis Manzano
    Calon, Alexandre
    [J]. CANCERS, 2023, 15 (04)
12345